| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AXSM | Axsome Therapeutics, Inc. | Kaye Randall | Chief Medical Officer | Dec 23, 2015 | Buy | $9.03 | 1,000 | 9,026 | 6,022 | Dec 24, 2015, 01:02 PM | |
| AXSM | Axsome Therapeutics, Inc. | Kaye Randall | Chief Medical Officer | Nov 24, 2015 | Option Exercise | $5.40 | 5,022 | 27,119 | 5,022 | Nov 24, 2015, 04:26 PM | |
| AVNR | AVANIR PHARMACEUTICALS, INC. | Kaye Randall | Sr. VP, Chief Medical Officer | Sep 09, 2011 | Sale | $2.75 | 100,000 | 275,000 | 65,690 | Sep 13, 2011, 05:01 PM | |
| AVNR | AVANIR PHARMACEUTICALS, INC. | Kaye Randall | Sr. VP, Chief Medical Officer | Jan 05, 2011 | Sale | $4.05 | 10,000 | 40,500 | 165,690 | Jan 07, 2011, 05:23 PM | |
| AVNR | AVANIR PHARMACEUTICALS, INC. | Kaye Randall | Sr. VP, Chief Medical Officer | Dec 13, 2010 | Option Exercise | $3.92 | 1,446 | 5,668 | 175,690 | Dec 15, 2010, 08:39 PM | |
| AVNR | AVANIR PHARMACEUTICALS, INC. | Kaye Randall | Sr. VP, Chief Medical Officer | Dec 06, 2010 | Sale | $3.80 | 10,000 | 38,000 | 177,136 | Dec 08, 2010, 12:33 PM | |
| AVNR | AVANIR PHARMACEUTICALS, INC. | Kaye Randall | Sr. VP, Chief Medical Officer | Nov 05, 2010 | Sale | $4.76 | 10,000 | 47,556 | 187,136 | Nov 08, 2010, 09:26 PM | |
| AVNR | AVANIR PHARMACEUTICALS, INC. | Kaye Randall | Sr. VP, Chief Medical Officer | Oct 05, 2010 | Sale | $3.23 | 10,000 | 32,269 | 227,036 | Oct 05, 2010, 08:25 PM | |
| AVNR | AVANIR PHARMACEUTICALS, INC. | Kaye Randall | Sr. VP, Chief Medical Officer | Sep 13, 2010 | Option Exercise | $2.70 | 1,447 | 3,907 | 237,036 | Sep 15, 2010, 06:13 PM | |
| AVNR | AVANIR PHARMACEUTICALS, INC. | Kaye Randall | Sr. VP, Chief Medical Officer | Sep 07, 2010 | Sale | $2.70 | 10,000 | 27,034 | 238,483 | Sep 08, 2010, 09:48 PM | |
| AVNR | AVANIR PHARMACEUTICALS, INC. | Kaye Randall | Sr. VP, Chief Medical Officer | Aug 18, 2010 | Sale | $3.08 | 35,000 | 107,664 | 248,483 | Aug 20, 2010, 07:18 PM | |
| AVNR | AVANIR PHARMACEUTICALS, INC. | Kaye Randall | Sr. VP, Chief Medical Officer | Aug 05, 2010 | Sale | $3.28 | 10,000 | 32,800 | 283,483 | Aug 09, 2010, 07:01 PM |
Menu